Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Esophagus/SPIRE1_pca_on_diff_genes.png) | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
Lung | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Lung/SPIRE1_pca_on_diff_genes.png) | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ |
IAC: Invasive lung adenocarcinoma |
MIA: Minimally invasive adenocarcinoma |
Prostate | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Prostate/SPIRE1_pca_on_diff_genes.png) | BPH: Benign Prostatic Hyperplasia |
Thyroid | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Thyroid/SPIRE1_pca_on_diff_genes.png) | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003253517 | Prostate | BPH | regulation of cellular component size | 108/3107 | 383/18723 | 6.41e-09 | 2.27e-07 | 108 |
GO:003083815 | Prostate | BPH | positive regulation of actin filament polymerization | 40/3107 | 99/18723 | 1.46e-08 | 4.62e-07 | 40 |
GO:003004116 | Prostate | BPH | actin filament polymerization | 63/3107 | 191/18723 | 1.94e-08 | 5.98e-07 | 63 |
GO:00516569 | Prostate | BPH | establishment of organelle localization | 107/3107 | 390/18723 | 3.67e-08 | 1.03e-06 | 107 |
GO:000806415 | Prostate | BPH | regulation of actin polymerization or depolymerization | 61/3107 | 188/18723 | 6.37e-08 | 1.68e-06 | 61 |
GO:003083316 | Prostate | BPH | regulation of actin filament polymerization | 57/3107 | 172/18723 | 7.52e-08 | 1.92e-06 | 57 |
GO:003083210 | Prostate | BPH | regulation of actin filament length | 61/3107 | 189/18723 | 7.89e-08 | 2.00e-06 | 61 |
GO:00009109 | Prostate | BPH | cytokinesis | 55/3107 | 173/18723 | 5.81e-07 | 1.15e-05 | 55 |
GO:005105410 | Prostate | BPH | positive regulation of DNA metabolic process | 58/3107 | 201/18723 | 9.08e-06 | 1.28e-04 | 58 |
GO:00450106 | Prostate | BPH | actin nucleation | 22/3107 | 52/18723 | 1.05e-05 | 1.44e-04 | 22 |
GO:200102015 | Prostate | BPH | regulation of response to DNA damage stimulus | 60/3107 | 219/18723 | 3.58e-05 | 3.92e-04 | 60 |
GO:00510529 | Prostate | BPH | regulation of DNA metabolic process | 89/3107 | 359/18723 | 4.07e-05 | 4.36e-04 | 89 |
GO:001082110 | Prostate | BPH | regulation of mitochondrion organization | 41/3107 | 144/18723 | 2.40e-04 | 1.92e-03 | 41 |
GO:00616404 | Prostate | BPH | cytoskeleton-dependent cytokinesis | 31/3107 | 100/18723 | 2.63e-04 | 2.06e-03 | 31 |
GO:00108226 | Prostate | BPH | positive regulation of mitochondrion organization | 24/3107 | 74/18723 | 6.06e-04 | 4.16e-03 | 24 |
GO:00325064 | Prostate | BPH | cytokinetic process | 15/3107 | 39/18723 | 8.91e-04 | 5.72e-03 | 15 |
GO:20010226 | Prostate | BPH | positive regulation of response to DNA damage stimulus | 28/3107 | 105/18723 | 5.97e-03 | 2.75e-02 | 28 |
GO:00516531 | Prostate | BPH | spindle localization | 17/3107 | 56/18723 | 7.62e-03 | 3.39e-02 | 17 |
GO:0051639 | Prostate | BPH | actin filament network formation | 6/3107 | 12/18723 | 7.73e-03 | 3.39e-02 | 6 |
GO:190290319 | Prostate | Tumor | regulation of supramolecular fiber organization | 131/3246 | 383/18723 | 6.68e-16 | 1.26e-13 | 131 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SPIRE1 | SNV | Missense_Mutation | rs753346539 | c.1094N>A | p.Arg365Gln | p.R365Q | Q08AE8 | protein_coding | tolerated(0.25) | benign(0.116) | TCGA-AR-A250-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
SPIRE1 | SNV | Missense_Mutation | rs769420628 | c.1912N>G | p.Ile638Val | p.I638V | Q08AE8 | protein_coding | tolerated(1) | benign(0.203) | TCGA-BH-A18Q-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SPIRE1 | deletion | Frame_Shift_Del | novel | c.2134delN | p.Ile712SerfsTer18 | p.I712Sfs*18 | Q08AE8 | protein_coding | | | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD |
SPIRE1 | SNV | Missense_Mutation | novel | c.833N>T | p.Arg278Met | p.R278M | Q08AE8 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
SPIRE1 | SNV | Missense_Mutation | novel | c.655N>A | p.Ala219Thr | p.A219T | Q08AE8 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
SPIRE1 | SNV | Missense_Mutation | novel | c.545N>A | p.Gly182Glu | p.G182E | Q08AE8 | protein_coding | tolerated(1) | benign(0) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
SPIRE1 | SNV | Missense_Mutation | novel | c.516N>T | p.Glu172Asp | p.E172D | Q08AE8 | protein_coding | tolerated(0.11) | probably_damaging(0.99) | TCGA-DS-A1OD-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | SD |
SPIRE1 | SNV | Missense_Mutation | rs764517052 | c.643A>T | p.Asn215Tyr | p.N215Y | Q08AE8 | protein_coding | deleterious(0.03) | probably_damaging(0.964) | TCGA-VS-A8EJ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
SPIRE1 | insertion | Frame_Shift_Ins | novel | c.517_518insCCCTCATCTTT | p.Gly173AlafsTer32 | p.G173Afs*32 | Q08AE8 | protein_coding | | | TCGA-DS-A1OD-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | SD |
SPIRE1 | SNV | Missense_Mutation | rs754818224 | c.722N>T | p.Ala241Val | p.A241V | Q08AE8 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |